$3.86 Billion is the total value of Rubric Capital Management LP's 71 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was - .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
IWM | New | ISHARES TRput | $1,346,920,000 | – | 7,550,000 | +100.0% | 34.92% | – |
STNG | New | SCORPIO TANKERS INC | $135,401,168 | – | 2,404,567 | +100.0% | 3.51% | – |
VST | New | VISTRA CORP | $59,055,960 | – | 2,460,665 | +100.0% | 1.53% | – |
FCNCA | New | FIRST CTZNS BANCSHARES INC Ncl a | $51,630,740 | – | 53,058 | +100.0% | 1.34% | – |
CSTM | New | CONSTELLIUM SE | $45,695,848 | – | 2,990,566 | +100.0% | 1.18% | – |
TEVA | New | TEVA PHARMACEUTICAL INDS LTDsponsored ads | $39,823,283 | – | 4,499,806 | +100.0% | 1.03% | – |
CTIC | New | CTI BIOPHARMA CORP | $37,645,675 | – | 8,963,256 | +100.0% | 0.98% | – |
OFIX | New | ORTHOFIX MED INC | $34,232,210 | – | 2,043,714 | +100.0% | 0.89% | – |
OUT | New | OUTFRONT MEDIA INC | $21,672,341 | – | 1,335,326 | +100.0% | 0.56% | – |
RDNT | New | RADNET INC | $10,147,638 | – | 405,419 | +100.0% | 0.26% | – |
BCYC | New | BICYCLE THERAPEUTICS PLCsponsored ads | $4,369,347 | – | 205,423 | +100.0% | 0.11% | – |
New | XERIS BIOPHARMA HOLDINGS INC | $694,815 | – | 426,267 | +100.0% | 0.02% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-12
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
MAGNACHIP SEMICONDUCTOR CORP | 28 | Q3 2023 | 4.7% |
BGC PARTNERS INC | 20 | Q2 2023 | 4.6% |
MR COOPER GROUP INC | 20 | Q3 2023 | 5.9% |
PAR PACIFIC HOLDINGS INC | 18 | Q3 2023 | 3.9% |
RADIUS HEALTH INC | 16 | Q2 2022 | 4.3% |
CLEAR CHANNEL OUTDOOR HLDGS | 16 | Q3 2023 | 2.6% |
HERON THERAPEUTICS INC | 15 | Q3 2023 | 9.0% |
COLLEGIUM PHARMACEUTICAL INC | 15 | Q3 2023 | 3.9% |
AAR CORP | 14 | Q3 2023 | 3.2% |
GREEN PLAINS INC | 14 | Q3 2022 | 4.1% |
View Rubric Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
HERON THERAPEUTICS, INC. /DE/ | July 25, 2023 | 26,713,503 | 19.0% |
Amryt Pharma plc | February 10, 2023 | 18,000,000 | 5.6% |
BGC Partners, Inc. | February 10, 2023 | 18,250,000 | 5.6% |
EverQuote, Inc. | February 10, 2023 | 1,246,622 | 4.8% |
Ferroglobe PLC | February 10, 2023 | 3,232,762 | 1.7% |
Sio Gene Therapies Inc. | February 10, 2023 | 7,000,000 | 9.5% |
Vincerx Pharma, Inc. | February 10, 2023 | 386,719 | 1.8% |
Whole Earth Brands, Inc. | February 10, 2023 | 998,363 | 2.4% |
Radius Health, Inc. | June 16, 2022 | 6,959,305 | 14.6% |
ANTARES PHARMA, INC. | February 14, 2022 | 10,800,000 | 6.4% |
View Rubric Capital Management LP's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
DFAN14A | 2024-05-01 |
DFAN14A | 2024-04-30 |
DFAN14A | 2024-04-29 |
DEFC14A | 2024-04-17 |
DFAN14A | 2024-04-17 |
SC 13D/A | 2024-04-16 |
PRRN14A | 2024-04-02 |
PRRN14A | 2024-03-26 |
DFAN14A | 2024-03-11 |
PREC14A | 2024-03-08 |
View Rubric Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.